Screening Study for the Department of Rehabilitation Medicine - Tabular View

Tracking Information
First Received Date ^ICMJE	August 22, 2001
Last Updated Date	July 18, 2008
Start Date ^ICMJE	April 1994
Primary Completion Date
Current Primary Outcome Measures ^ICMJE
Original Primary Outcome Measures ^ICMJE (submitted: October 19, 2007)	To determine the maximum tolerated dose of systemically delivered, heat-activated liposome encapsulated doxorubicin (Thermodox) in combination with radiofrequency ablation (RFA) of liver neoplasms.
Change History	Complete list of historical versions of study NCT00023088 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures ^ICMJE
Original Secondary Outcome Measures ^ICMJE (submitted: October 19, 2007)	To document any antitumor activity.

Descriptive Information
Brief Title ^ICMJE	Screening Study for the Department of Rehabilitation Medicine
Official Title ^ICMJE	Rehabilitation Medicine Screening Protocol
Brief Summary	The primary function of the Department of Rehabilitation Medicine (RMD) is to diagnose and treat patients at the NIH who have problems in locomotion, activities of daily living, occupational roles, communication, swallowing, or problems with chronic pain. The major goal of this department s to help patients achieve maximal function so that they can resume their daily living activities as normal as possible. In order for the department to accomplish it's goal it requires the involvement of medical staff and the use of a variety of tests and instruments. Before a new test, evaluation technique, or piece of physical equipment can be considered for use in the treatment of patients it must be carefully studied. Researchers must make sure the test, technique, or instrument is safe, sensitive, accurate, specific, and reproducible. Therefore all of these tests, techniques, and instruments must first undergo a trial period. Normal volunteers and patients from the RMD and outside of the RMD may be selected to participate in the trial period. This study provides a framework for researchers in the Department of Rehabilitation Medicine (RMD) to develop new tests, techniques, technology, and equipment.
Detailed Description	This protocol provides a framework for clinicians in the Department of Rehabilitation Medicine (RMD) to develop and pilot new tests, techniques, technology, or equipment to remain state-of-the-art.
Study Phase
Study Type ^ICMJE	Observational
Study Design ^ICMJE
Condition ^ICMJE	Convalescence Healthy
Intervention ^ICMJE
Study Arms / Comparison Groups
Publications *
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information
Recruitment Status ^ICMJE	Completed
Enrollment ^ICMJE	600
Completion Date	July 2008
Primary Completion Date
Eligibility Criteria ^ICMJE	INCLUSION CRITERIA: In- and outpatients referred to the Rehabilitation Medicine Department. Normal volunteers of either sex.
Gender	Both
Ages
Accepts Healthy Volunteers	Yes
Contacts ^ICMJE	Contact information is only displayed when the study is recruiting subjects
Location Countries ^ICMJE	United States

Administrative Information
NCT ID ^ICMJE	NCT00023088
Responsible Party
Study ID Numbers ^ICMJE	940130, 94-CC-0130
Study Sponsor ^ICMJE	National Institutes of Health Clinical Center (CC)
Collaborators ^ICMJE
Investigators ^ICMJE
Information Provided By	National Institutes of Health Clinical Center (CC)
Verification Date	July 2008
^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP